Abstract
While there are numerous options for treatment of small (<4 cm) renal masses, irreversible electroporation (IRE) is a unique method of ablation which is reliable, safe and effective. Unlike other ablation methods, there is no need to cool the ureter or separate the colon from the kidney by injecting fluid into the perinephric space. Even when lesions extend into the central portion of the kidney, IRE is not associated with significant bleeding or haematuria. IRE is especially effective in the elderly or those with impaired renal function.
This is a preview of subscription content, log in via an institution to check access.
References
American Cancer Society. Cancer facts and figures 2000. Atlanta: American Cancer Society; 2000. p. 4.
Russo P. Renal cell carcinoma: presentation, staging, and surgical treatment. Semin Oncol. 2000;27:160–76. Medline.
Cohan RH, Sherman LS, Korobkin M, Bass JC, Francis IR. Renal masses: assessment of corticomedullary-phase and nephrographic-phase CT scans. Radiology. 1995;196:445–51. Link.
Kopka L, Fischer U, Zoeller G, Schmidt C, Ringert RH, Grabbe E. Dual-phase helical CT of the kidney: value of the corticomedullary and nephrographic phase for evaluation of renal lesions and preoperative staging of renal cell carcinoma. AJR Am J Roentgenol. 1997;169:1573–8. CrossRef, Medline.
Szolar DH, Kammerhuber F, Altziebler S, et al. Multiphasic helical CT of the kidney: increased conspicuity for detection and characterization of small (<3-cm) renal masses. Radiology. 1997;202:211–7. Link.
Yuh BI, Cohan RH. Different phases of renal enhancement: role in detecting and characterizing renal masses during helical CT. AJR Am J Roentgenol. 1999;173:747–55. CrossRef, Medline.
Silverman SG, Lee BY, Seltzer SE, Bloom DA, Corless CL, Adams DF. Small (<3-cm) renal masses: correlation of spiral CT features and pathologic findings. AJR Am J Roentgenol. 1994;163:597–605. Cros allsRef, Medline.
Pech M1, Janitzky A, Wendler JJ, Strang C, Blaschke S, Dudeck O, Ricke J, Liehr UB. Irreversible electroporation of renal cell carcinoma: a first-in-man phase I clinical study. Cardiovasc Intervent Radiol. 2011;34:132–8.
Wagstaff P, de Bruin DM, Zondervan PJ, Heijink CD, Engelbrecht MRW, van Delden OM, van Leeuwen TG, Wijkstra H, de la Rosette JJ, Pes MP. The efficacy and safety of irreversible electroporation for the ablation of renal masses: a prospective, human, in-vivo study protocol. BMC Cancer. 2015;15:165.
Deodhar A, Monette S, Single GW Jr, Hamilton WC Jr, Thornton R, Maybody M, Coleman JA, Solomon SB. Renal tissue ablation with irreversible electroporation. Preliminary results in a porcine model. Urology. 2011;77:754–60.
Trimmer CK, Khosla A, Morgan M, Stephenson SL, Ozayar A, Cadeddu JA. Minimally invasive percutaneous treatment of small renal tumours with irreversible electroporation: a single centre experience. JVIR. 2015;26:1465–71.
Wehle MJ, Thiel DD, Petrou SP, Young PR, Frank I, Karsteadt N. Conservative management of incidental contrast-enhancing renal masses as safe alternative to invasive therapy. Urology. 2004;64:49–52.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Koukounaras, J., Kavnoudias, H., Thomson, K.R. (2018). Irreversible Electroporation of Kidney Tumours. In: Meijerink, M., Scheffer, H., Narayanan, G. (eds) Irreversible Electroporation in Clinical Practice. Springer, Cham. https://doi.org/10.1007/978-3-319-55113-5_13
Download citation
DOI: https://doi.org/10.1007/978-3-319-55113-5_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-55112-8
Online ISBN: 978-3-319-55113-5
eBook Packages: MedicineMedicine (R0)